Eslicarbazepine acetate as adjunctive therapy in clinical practice: ESLADOBA study.
Journal Information
Full Title: Acta Neurol Scand
Abbreviation: Acta Neurol Scand
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST Role of funding source: This study was initiated, designed, and sponsored by BIAL – Portela & Ca. SA. BIAL—Portela & Ca. SA. was involved in the review of this manuscript. João Chaves received speaker's honoraria and/or consultancy fees from BIAL and Eisai. Hélder Fernandes, Rui Sousa and Acílio Gala are employees of BIAL—Portela & Ca. SA."
Funding Disclosure
Evidence found in paper:
"Funding information"
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025